https://www.macrotrends.net/stocks/charts/KPRX/kiora-pharmaceuticals/net-income
Kiora Pharmaceuticals net income from 2013 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses...
net incomekiorapharmaceuticalskprxmacrotrends
https://www.macrotrends.net/stocks/charts/KPRX/kiora-pharmaceuticals/cash-on-hand
Kiora Pharmaceuticals cash on hand from 2013 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn...
kiorapharmaceuticalscashhandkprx
https://www.newsfilecorp.com/release/218152/Kiora-Pharmaceuticals-Receives-European-Orphan-Medicinal-Product-Designation-for-KIO301-for-the-Treatment-of-Inherited-Retinal-Dystrophies
Encinitas, California--(Newsfile Corp. - July 30, 2024) - Kiora Pharmaceuticals (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it has...
medicinal productkiorapharmaceuticalsreceiveseuropean